… There were minimal data on the risk of virus transmission via nebulization from the previous
… or English language but could not read due to some reasons such as visual impairment. …

… risk of developing pneumonia, 72 and most patients with moderate to severe COPD are treated
with inhaled steroids that further increase the risk of … receive inhaled bronchodilators and …

… and more pack/years) and/or other inhaled risks, aged 40 – 69 years and with symptoms of
… disease symptoms, reduction in ICS and inhaled bronchodilators’ need as well as reduction …

The purpose of this review is to summarize essential pharmacological, pharmaceutical, and
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …

… of bronchodilator treatment … hazards for the patient using the nebulizer; to reduce the risk
of affecting other people, patients should follow social distancing guidance and avoid nebulizer …

… In one study, albuterol by nebulizer 10–30 min prior to surgery reduced the risk (RR 0.35) of
… no albuterol use. Interestingly, the same group performed another randomized trial in which …

… When multiple bursts of SCS are prescribed, there is an amplified risk for complications and
… who are unresponsive to increased inhaled bronchodilator containing medications; once …

… cessation and inhaled bronchodilator therapy indicated cancer was the most common
cause of mortality (33%) [3]. However, in a pooled analysis of seven randomized clinical trials …

… Warn patients to seek medical advice if short-acting inhaled bronchodilator use increases.
Therapy should not be abruptly stopped without physician supervision due to risk of symptom …

… Ocular hypertension secondary to … induced ocular hypertension (SIOH) has been linked to
a range of drug delivery routes including oral or intravenous, inhaled or intranasal, topical eye …